Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis

被引：40

作者：

Ortoneda, M ^{[1
]}

Capilla, J ^{[1
]}

Pastor, FJ ^{[1
]}

Serena, C ^{[1
]}

Guarro, J ^{[1
]}

机构：

[1] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Unitat Microbiol, E-43201 Reus, Spain

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2004年 / 50卷 / 04期

关键词：

Scedosporium prolificans; liposomal amphotericin B; G-CSF;

D O I：

10.1016/j.diagmicrobio.2004.07.011

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Because human infections by Scedosporium prolificans are difficult to treat and show a very poor outcome, new therapeutic strategies are needed. Liposomal amphotericin B (LAMB) (40 mg/kg/day) increased significantly the mean survival time in immunosuppressed mice compared with a control group (22.6 vs. 8.8 days). Amphotericin B deoxycholate (1.5 mg/kg/day) and granulocyte colony-stimulating factor (G-CSF) (300 mug/kg/day) were ineffective. The combination of LAMB (40 mg/kg/day) and G-CSF (150 or 300 mug/kg/day) did not improve the results obtained with LAMB alone. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：247 / 251

页数：5

共 20 条

[1] Deep infections caused by Scedosporium prolificans - A report on 16 cases in Spain and a review of the literature
Berenguer, J
RodriguezTudela, JL
Richard, C
Alvarez, M
Sanz, MA
Gaztelurrutia, L
Ayats, J
MartinezSuarez, JV
[J]. MEDICINE, 1997, 76 (04) : 256 - 265
[2] Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor
Bouza, E
Munoz, P
Vega, L
RodriguezCreixems, M
Berenguer, J
Escudero, A
[J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) : 192 - 193
[3] Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits
Capilla, J
Yustes, C
Mayayo, E
Fernández, B
Ortoneda, M
Pastor, FJ
Guarro, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) : 1948 - 1951
[4] In vitro activities of four novel triazoles against Scedosporium spp.
Carrillo, AJ
Guarro, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2151 - 2153
[5] Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-γ
Clemons, KV
Stevens, DA
[J]. MEDICAL MYCOLOGY, 2000, 38 (03) : 213 - 219
[6] Amphotericin B nephrotoxicity
Deray, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 : 37 - 41
[7] Overview of the lipid formulations of amphotericin B
Dupont, B
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 : 31 - 36
[8] Immunotherapy in patients with systemic mycoses - A promising adjunct
Farmaki, E
Roilides, E
[J]. BIODRUGS, 2001, 15 (04) : 207 - 214
[9] Graybill JR, 1997, J MED VET MYCOL, V35, P243
[10] Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: Role of immune suppression
Graybill, JR
Bocanegra, R
Najvar, LK
Loebenberg, D
Luther, MF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2467 - 2473

← 1 2 →